A detailed history of Covestor LTD transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Covestor LTD holds 1,811 shares of ITCI stock, worth $156,524. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,811
Previous 1,290 40.39%
Holding current value
$156,524
Previous $88,000 51.14%
% of portfolio
0.08%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$67.99 - $80.84 $35,422 - $42,117
521 Added 40.39%
1,811 $133,000
Q2 2024

Aug 09, 2024

SELL
$64.76 - $79.84 $87,685 - $108,103
-1,354 Reduced 51.21%
1,290 $88,000
Q1 2024

May 10, 2024

SELL
$64.37 - $75.65 $11,844 - $13,919
-184 Reduced 6.51%
2,644 $183,000
Q4 2023

Feb 09, 2024

BUY
$46.37 - $73.65 $14,374 - $22,831
310 Added 12.31%
2,828 $203,000
Q3 2023

Nov 13, 2023

BUY
$52.09 - $64.1 $51,621 - $63,523
991 Added 64.9%
2,518 $131,000
Q2 2023

Aug 11, 2023

SELL
$54.67 - $66.44 $49,531 - $60,194
-906 Reduced 37.24%
1,527 $97,000
Q1 2023

May 15, 2023

BUY
$43.8 - $56.99 $14,716 - $19,148
336 Added 16.02%
2,433 $132,000
Q4 2022

Feb 13, 2023

BUY
$44.07 - $54.45 $9,210 - $11,380
209 Added 11.07%
2,097 $110,000
Q3 2022

Nov 14, 2022

BUY
$42.7 - $59.99 $72,547 - $101,923
1,699 Added 898.94%
1,888 $88,000
Q2 2022

Aug 10, 2022

BUY
$43.0 - $65.64 $7,611 - $11,618
177 Added 1475.0%
189 $11,000
Q1 2022

May 13, 2022

SELL
$38.74 - $62.09 $116 - $186
-3 Reduced 20.0%
12 $1,000
Q4 2021

Feb 10, 2022

BUY
$35.2 - $53.42 $528 - $801
15 New
15 $1,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.16B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.